{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:14:01Z","timestamp":1767676441496,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.biopha.2004.10.002","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T13:47:18Z","timestamp":1099921638000},"page":"605-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diabetes mellitus: rational basis, clinical approach and future therapy"],"prefix":"10.1016","volume":"58","author":[{"given":"Hisako","family":"Ohgawara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Edamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2004.10.002_bib1","first-page":"886","article-title":"The absence of a glycemic threshold for the development of long-term complications; the perspective of the Diabetes Control and Complication Trial","volume":"41","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2004.10.002_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.6776628","article-title":"Microencapsulated islets as bio-artificial endocrine pancreas","volume":"210","author":"Lim","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.biopha.2004.10.002_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2337\/diab.30.4.296","article-title":"Functional evaluation of a bio-artificial pancreas using isolated islets perfused with blood ultrafiltrate","volume":"30","author":"Reach","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2004.10.002_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.2024124","article-title":"Biohybrid artificial pancreas: long-term implantation studies in diabetic pancreatectomized dogs","volume":"252","author":"Sullivan","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.biopha.2004.10.002_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2337\/diab.41.7.886","article-title":"Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas","volume":"41","author":"Lanza","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2004.10.002_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/diab.40.1.37","article-title":"Wolters GHJ, Scifgaarode RV. Effect of arginate-polylysin-alginate microencapsulation in in vitro insulin release from rat pancreatic islets","volume":"40","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2004.10.002_bib7","first-page":"7","article-title":"N-isopropylaryamide and methacrylate copolymers for encapsulation of islets","volume":"14","author":"Iwata","year":"1990","journal-title":"Artif. Organs"},{"key":"10.1016\/j.biopha.2004.10.002_bib8","first-page":"313","article-title":"Problems in the use of polycarbonate diffusion chambers for syngeneic pancreatic islet transplantation in rats","volume":"18","author":"Theodoroes","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2004.10.002_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/096368979500400309","article-title":"Embedded-culture of pancreatic \u03b2-cells derived from transgenic mouse insulinoma as a potential source for xenotransplantation using a diffusion chamber","volume":"4","author":"Ohgawara","year":"1995","journal-title":"Cell Transplant."},{"key":"10.1016\/j.biopha.2004.10.002_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0041-1345(97)01368-7","article-title":"A bio-artificial endocrine pancreas for the treatment of diabetes","volume":"30","author":"Hirotani","year":"1998","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.biopha.2004.10.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8227(98)00096-5","article-title":"Establishment of monolayer culture of pig pancreatic endocrine cells by use of nicotinamide","volume":"42","author":"Ohgawara","year":"1998","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2004.10.002_bib12","series-title":"62nd ADA-meeting at San Francisco","article-title":"A bioartificial endocrine pancreas for the treatment of diabetes","author":"Ohgawara","year":"2002"},{"key":"10.1016\/j.biopha.2004.10.002_bib13","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(94)90570-3","article-title":"Transplantation of porcine fetal pancreas to diabetic patients","volume":"344","author":"Groth","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2004.10.002_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1525-1594.1998.06185.x","article-title":"Membrane immunoisolation of a diffusion chamber for a bio-artificial pancreas","volume":"22","author":"Ohgawara","year":"1998","journal-title":"Artif. Organs"},{"key":"10.1016\/j.biopha.2004.10.002_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1292\/jvms.66.129","article-title":"Prevalence of porcine endogenous retrovirus in domestic pigs in Japan and its potential Infection in dogs xenotransplanted with porcine pancreatic islet cells","volume":"66","author":"Edamura","year":"2004","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.biopha.2004.10.002_bib16","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1058866","article-title":"Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets","volume":"292","author":"Lumelsky","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopha.2004.10.002_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2337\/diabetes.50.3.521","article-title":"Multipotential nestin- positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes","volume":"50","author":"Zulewski","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2004.10.002_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0163-7258(03)00050-0","article-title":"Molecular design and biological activities of protein-tyrosine phosphatase inhibitors","volume":"99","author":"Umezawa","year":"2003","journal-title":"Pharmacol. Therapeutics"},{"key":"10.1016\/j.biopha.2004.10.002_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0753-3322(03)00096-9","article-title":"Induction of insulin production in rat pancreatic acinar carcinoma cells by conophylline. Biomed","volume":"57","author":"Umezawa","year":"2003","journal-title":"Pharmacother."},{"key":"10.1016\/j.biopha.2004.10.002_bib20","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.2337\/diabetes.53.10.2596","article-title":"Promotion of \u03b2-cell differentiation by conophylline in fetal and neonatal rat pancreas.","volume":"53","author":"Ogata","year":"2004","journal-title":"Diabetes"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332204001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332204001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:34:56Z","timestamp":1760092496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332204001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0753332204001684"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2004.10.002","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes mellitus: rational basis, clinical approach and future therapy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2004.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}